摘要
目的探究微创颅内血肿清除术对高血压脑出血患者治疗效果、血肿清除率及神经功能的影响。方法方便选取高血压脑出血患者72例,在该院于2017年1月—2018年1月进行治疗,观察组及对照组,各36例。取内科保守治疗为对照组,采用微创颅内血肿清除术治疗的是观察组。在结束治疗之后,对比两组患者治疗效果。结果在手术治疗之后观察组神经功能评分(13.1±9.7)分,对照组(25.3±11.3)分,相较于术前,两组患者对比,差异有统计学意义(P<0.05);且相较于对照组术后神经功能评分,观察组较为优异,差异有统计学意义(t=4.9153,P<0.05);对照组患者死于脑疝的6例,肾功能衰竭2例,肺部感染和消化道出血各3例,共死亡14例(38.89%);观察组肾功能衰竭、脑疝形成、肺部感染各1例,总死亡3例(8.33%)。总清除率平均为(78.6±21.4)%,血肿初次清除率平均为(56.5±18.5)%,均于1~2周内消失。两组对比差异有统计学意义(P<0.05);相较于对照组,观察组ADL较为优异,差异有统计学意义(P<0.05)。结论应用微创颅内血肿清除术治疗高血压脑出血患者,能够加快患者康复速度,缓解临床症状,改善患者生活质量,减少患者死亡率,取得显著性治疗效果,具有临床应用价值。
Objective To investigate the therapeutic effect, hematoma removal rate and God of minimally invasive intracranial hematoma removal in patients with hypertensive intracerebral hemorrhage and the effect of the warp function. Methods 72 Patients with hypertensive intracerebral hemorrhage were convenient selected and treated in our hospital from January 2017 to January 2018, and in the Observation Group and control group, two groups were 36 cases. The conservative treatment of internal medicine was taken as the control group, and the observation group was treated by minimally invasive intracranial hematoma removal. After the end of treatment, the treatment effect was compared between the two groups of patients. Results After surgical treatment, the neurological function score (13.1±9.7)points of the group was divided into the control group (25.3±11.3)points, compared with that of the two groups before Operation the difference is statistically significant (P<0.05), and compared with the control group after the postoperative neurological function score, the observation group is more excellent, the difference is statistically significant (t=4.915 3,P<0.05), the control group patients died in 6 cases of cerebral hernia, renal failure 2 cases, lung infection and gastrointestinal hemorrhage 3 cases, a total of 14 cases of death (38.89%);1 cases of renal failure, cerebral hernia formation and pulmonary infection in the observation Group, 3 cases of total death (8.33%). The total clearance rate averaged (78.6±21.4)% and the initial clearance rate for hematoma was (56.5±18.5)%, all disappearing within 1-2 weeks. The contrast difference between the two groups was statistically significant (P<0.05), compared with the control group, the ADL of the observation group was excellent, the difference was statistically significant (P<0.05). Conclusion The application of minimally invasive intracranial hematoma removal in the treatment of hypertensive intracerebral hemorrhage can speed up the rehabilitation of patients, alleviate clinical symptoms, improve the quality of life of patients, reduce the mortality rate of patients, achieve significant therapeutic effect, and has clinical application value.
作者
张玉年
ZHANG Yu-nian(Department of Neurosurgery, Junan County People's Hospital, Junan Shandong Province, 276000 China)
出处
《中外医疗》
2019年第10期77-80,共4页
China & Foreign Medical Treatment
关键词
高血压脑出血
微创颅内血肿清除术
神经功能
血肿清除率
Hypertensive cerebral hemorrhage
Minimally invasive intracranial hematoma removal
Neurological function
Hematoma clearance